<DOC>
	<DOCNO>NCT02391688</DOCNO>
	<brief_summary>Phenotyping approach largely used evaluation activity cytochromes transporter vivo . It consist administration probe substance metabolise specific cytochrome transport P-glycoprotein ( P-gp ) example , follow determination metabolic ratio evaluation plasmatic urinary concentration probe substance . The administration cocktail contain several probe substance allow simultaneous evaluation activity several cytochrome P-gp single test . When cocktail approach use important make sure drug-drug interaction occur probe within cocktail . The validation lack interaction , aim study , consist demonstrate difference pharmacokinetic parameter and/or metabolic ratio probe administer alone part cocktail . The Geneva cocktail consist caffeine , bupropion , flurbiprofen , omeprazole , dextromethorphan , midazolam fexofenadine simultaneous phenotyping CYP1A2 , CYP2B6 , CYP2C9 , CAP2C19 , CYP2D6 , CYP3A4 P-gp , respectively . Probe metabolite concentration measure capillary blood use dry blood spot ( DBS ) analysis . To facilitate sampling , new simple device use ensure precision capillary blood collection .</brief_summary>
	<brief_title>Evaluation Potential Pharmacokinetic Interactions Between Probe Drugs Geneva Phenotyping Cocktail</brief_title>
	<detailed_description />
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Flurbiprofen</mesh_term>
	<criteria>Healthy volunteer age 18 60 year BMI 18 27 Understanding French language able give write inform consent . smoker pregnant woman take drug alter cytochrome P450 ( CYP ) activity renal hepatic impairment medical history chronic alcoholism abuse psychoactive drug liver transplantation sensitivity drug use Alteration hepatic test , 2x normal ( aspartate transaminase &gt; 100U/L ; alanine transaminase &gt; 100 units/L ; gammaglutamyl transferase &gt; 80 units/L ; bilirubin &gt; 50Âµmol/L ) Presenting genetic polymorphism poor CYP2C9 , CYP2C19 , CYP2D6 metabolizer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>